Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
1-17
Author(s):
M. A. Jordan
Novel Aspects of Natural and Modified Vinca Alkaloids
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
55-70
Author(s):
Alain Duflos, Anna Kruczynski and Jean-Marc Barret
The Biology and Medicinal Chemistry of Epothilones
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
123-148
Author(s):
M. Wartmann and K. -H. Altmann
SUBJECT INDEX TO VOLUME 1
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
151-153
Author(s):
Science Publishers Bentham
Gene Therapy: Optimising DNA Delivery to the Nucleus
Journal:
Current Drug Targets
Volume:
2
Page:
371-399
Author(s):
Melanie Johnson-Saliba and David A. Jans
Raloxifene
Journal:
Current Drug Targets
Volume:
2
Page:
423-425
Author(s):
John A. Kellen
Preface
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
i-i
Author(s):
Michael Kassiou
Radiolabelled Tracers and Anticancer Drugs for Assessment of Therapeutic Efficacy Using PET
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1863-1892
Author(s):
Frank Brady, Sajinder K. Luthra, Gavin D. Brown, Safiye Osman, Eric Aboagye, Azeem Saleem and Patricia M. Price
Editorial
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
i-i
Author(s):
Antonio J. Grillo-Lopez, Anne McClure and Brian K. Dallaire
The History and Rationale for Monoclonal Antibodies in the Treatment of Hematologic Malignancy
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
293-300
Author(s):
R.O. Dillman